Sii Investments Inc. WI boosted its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 14.1% during the first quarter, Holdings Channel reports. The fund owned 1,700 shares of the medical instruments supplier’s stock after buying an additional 210 shares during the period. Sii Investments Inc. WI’s holdings in Becton, Dickinson and were worth $311,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Crestwood Advisors Group LLC purchased a new position in Becton, Dickinson and during the first quarter valued at $101,000. North Star Investment Management Corp. raised its position in Becton, Dickinson and by 3.4% in the first quarter. North Star Investment Management Corp. now owns 549 shares of the medical instruments supplier’s stock valued at $101,000 after buying an additional 18 shares during the last quarter. Parkside Financial Bank & Trust raised its position in Becton, Dickinson and by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock valued at $116,000 after buying an additional 9 shares during the last quarter. Financial Architects Inc raised its position in Becton, Dickinson and by 62.7% in the first quarter. Financial Architects Inc now owns 677 shares of the medical instruments supplier’s stock valued at $124,000 after buying an additional 261 shares during the last quarter. Finally, QCI Asset Management Inc. NY raised its position in Becton, Dickinson and by 9.2% in the first quarter. QCI Asset Management Inc. NY now owns 710 shares of the medical instruments supplier’s stock valued at $130,000 after buying an additional 60 shares during the last quarter. Institutional investors own 75.71% of the company’s stock.

Shares of Becton, Dickinson and Company (BDX) traded up 0.16% during trading on Wednesday, hitting $196.94. 245,863 shares of the stock traded hands. Becton, Dickinson and Company has a 52-week low of $161.29 and a 52-week high of $206.63. The firm has a market cap of $42.01 billion, a PE ratio of 32.71 and a beta of 1.05. The company’s 50 day moving average is $198.24 and its 200 day moving average is $186.80.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share for the quarter, beating analysts’ consensus estimates of $2.44 by $0.02. The firm had revenue of $3.04 billion for the quarter, compared to analysts’ expectations of $3.06 billion. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. Becton, Dickinson and’s revenue was down 5.1% compared to the same quarter last year. During the same period in the previous year, the company posted $2.35 earnings per share. On average, equities research analysts predict that Becton, Dickinson and Company will post $9.45 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 8th will be given a dividend of $0.73 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a yield of 1.49%. Becton, Dickinson and’s dividend payout ratio (DPR) is 83.43%.

WARNING: “Becton, Dickinson and Company (BDX) Position Increased by Sii Investments Inc. WI” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.dailypolitical.com/2017/08/09/becton-dickinson-and-company-bdx-position-increased-by-sii-investments-inc-wi.html.

BDX has been the topic of several recent analyst reports. BidaskClub lowered shares of Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Bank of America Corporation reiterated a “buy” rating and issued a $225.00 target price (up from $200.00) on shares of Becton, Dickinson and in a report on Friday, July 21st. Zacks Investment Research upgraded shares of Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 target price on the stock in a report on Monday, July 17th. Stifel Nicolaus reiterated a “buy” rating on shares of Becton, Dickinson and in a report on Wednesday. Finally, Royal Bank Of Canada reiterated a “hold” rating and issued a $177.00 target price on shares of Becton, Dickinson and in a report on Thursday, April 13th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $194.69.

In other Becton, Dickinson and news, VP Jeffrey S. Sherman sold 28,765 shares of Becton, Dickinson and stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the transaction, the vice president now directly owns 70,821 shares of the company’s stock, valued at $13,171,289.58. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders own 1.40% of the company’s stock.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.